Oligohydramnios

MONDO:0005881

A lower than normal quantity of amniotic fluid in the amniotic sac as compared to normal values. Typically associated with an amniotic fluid index (AFI) of less than 5 cm or a single maximum vertical pocket (MVP) of less than 2 cm.

Also known as: oligohydramnios, oligohydramnios (disease)

7 clinical trials for this condition and its sub-types, 5 tagged with Oligohydramnios itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Placenta disorder (163)

Sub-types of Oligohydramnios

Potter sequence 1 trial

Including sub-types (7) Tagged with Oligohydramnios (5)

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Kidney drug trial for newborns halted before it began

Disease control Cancelled

This study aimed to see if the drug tolvaptan could help infants with a severe form of polycystic kidney disease (ARPKD) avoid needing dialysis or a kidney transplant in their first year of life. The trial was planned for babies between 28 days and 12 weeks old, but it was withdr…

Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

Oligohydramnios

Where it sits in the disease tree

Kidney drug trial for newborns halted before it began